
Eisai Co., Ltd. – OTC:ESALF
Eisai Co., Ltd. stock price today
Eisai Co., Ltd. stock price monthly change
Eisai Co., Ltd. stock price quarterly change
Eisai Co., Ltd. stock price yearly change
Eisai Co., Ltd. key metrics
Market Cap | 16.74B |
Enterprise value | 1.00T |
P/E | 35.48 |
EV/Sales | 1.36 |
EV/EBITDA | 15.41 |
Price/Sales | 1.52 |
Price/Book | 1.29 |
PEG ratio | N/A |
EPS | 109.41 |
Revenue | 782.57B |
EBITDA | 63.55B |
Income | 31.38B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 4.45% |
Oper. margin | 3.43% |
Gross margin | 79.4% |
EBIT margin | 3.43% |
EBITDA margin | 8.12% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEisai Co., Ltd. stock price history
Eisai Co., Ltd. stock forecast
Eisai Co., Ltd. financial statements
Dec 2021 | 202.97B | 14.15B | 6.98% |
---|---|---|---|
Mar 2022 | 190.90B | -12.40B | -6.5% |
Mar 2023 | 198.20B | 16.32B | 8.24% |
Mar 2024 | 190.49B | 13.30B | 6.99% |
2026 | 746.64B | 55.60B | 7.45% |
---|---|---|---|
2027 | 783.69B | 62.23B | 7.94% |
2028 | 866.95B | 68.97B | 7.96% |
2029 | 949.70B | 86.01B | 9.06% |
Analysts Price target
Financials & Ratios estimates
Paying a dividend greater than earnings.
Payout ratio | 140.67% |
---|
2020 | 2.36% |
---|---|
2021 | 2.02% |
2022 | 2.83% |
2023 | 2.11% |
2024 | 2.63% |
Sep 2022 | 1261278000000 | 410.57B | 32.55% |
---|---|---|---|
Dec 2022 | 1251069000000 | 453.99B | 36.29% |
Mar 2023 | 1263350000000 | 440.77B | 34.89% |
Mar 2024 | 1393799000000 | 494.82B | 35.5% |
Dec 2021 | 4.76B | -10.70B | -25.49B |
---|---|---|---|
Mar 2022 | 44.41B | -10.18B | 4.47B |
Mar 2023 | 23.99B | -2.54B | -26.44B |
Mar 2024 | 18.05B | -2.98B | -9.34B |
Eisai Co., Ltd. alternative data
Aug 2023 | 11,076 |
---|---|
Sep 2023 | 11,076 |
Oct 2023 | 11,076 |
Nov 2023 | 11,076 |
Dec 2023 | 11,076 |
Jan 2024 | 11,076 |
Feb 2024 | 11,076 |
Apr 2024 | 11,076 |
May 2024 | 11,076 |
Jun 2024 | 11,076 |
Jul 2024 | 11,067 |
Eisai Co., Ltd. other data
Quarter | Transcript |
---|---|
Q4 2024 16 May 2024 | Q4 2024 Earnings Call Transcript |
Q3 2023 6 Feb 2024 | Q3 2023 Earnings Call Transcript |
Q2 2023 7 Nov 2023 | Q2 2023 Earnings Call Transcript |
Q4 2022 15 May 2023 | Q4 2022 Earnings Call Transcript |
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With U.S. Biopharma
Eisai: Margin Of Safety From Very Modest Penetration Expectations
Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
Week In Review: I-Mab Morphs Into U.S.-Only Company, Sells China Assets For $80M
Biogen: LAQEMBI's $10 Billion Potential
Eli Lilly: Does 'Miracle' Weight Loss Franchise Justify Rising Price Tag?
Acumen: A First In Targeting, May Lead To Improvement For Early AD Patients
Eisai: Looking To Upside Targets Following Leqembi Full Approval
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC
-
What's the price of Eisai Co., Ltd. stock today?
One share of Eisai Co., Ltd. stock can currently be purchased for approximately $32.19.
-
When is Eisai Co., Ltd.'s next earnings date?
Unfortunately, Eisai Co., Ltd.'s (ESALF) next earnings date is currently unknown.
-
Does Eisai Co., Ltd. pay dividends?
Yes, Eisai Co., Ltd. pays dividends and its trailing 12-month yield is 4.22% with 141% payout ratio.It means that the company is paying a dividend greater than earnings. The last Eisai Co., Ltd. stock dividend of undefined was paid on 7 Sep 2025.
-
How much money does Eisai Co., Ltd. make?
Eisai Co., Ltd. has a market capitalization of 16.74B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.36% to 741.75B US dollars.
-
What is Eisai Co., Ltd.'s stock symbol?
Eisai Co., Ltd. is traded on the OTC under the ticker symbol "ESALF".
-
What is Eisai Co., Ltd.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Eisai Co., Ltd.?
Shares of Eisai Co., Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Eisai Co., Ltd. have?
As Jul 2024, Eisai Co., Ltd. employs 11,067 workers, which is 0% less then previous month and 0% less then previous quarter.
-
When Eisai Co., Ltd. went public?
Eisai Co., Ltd. is publicly traded company for more then 14 years since IPO on 7 Apr 2011.
-
What is Eisai Co., Ltd.'s official website?
The official website for Eisai Co., Ltd. is eisai.co.jp.
-
How can i contact Eisai Co., Ltd.?
Eisai Co., Ltd. can be reached via phone at +81 3 3817 3700.
Eisai Co., Ltd. company profile:

Eisai Co., Ltd.
eisai.co.jpOTC
11,322
Drug Manufacturers—Specialty & Generic
Healthcare
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Tokyo, 112-8088
:
ISIN: JP3160400002
: